In the realm of cancer treatment, the debate between lorlatinib and alectinib has gained significant attention. These two medications, both used in the treatment of non-small cell lung cancer (NSCLC), have distinct mechanisms and potential benefits. This article aims to provide a comprehensive analysis of lorlatinib vs alectinib, focusing on their differences, similarities, and potential...